Search Results

There are 8745 results for: content related to: Ponatinib-induced neutrophilic panniculitis

  1. Pharmacogenomics of Dasatinib (Sprycel™)

    Kinase Inhibitor Drugs

    Fei Huang, Edwin A. Clark, Pages: 365–402, 2009

    Published Online : 28 SEP 2009, DOI: 10.1002/9780470524961.ch15

  2. Enzyme- and Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase Inhibitors

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 12, December 2014, Pages: 3810–3833, Jie Shao, John S. Markowitz, Di Bei and Guohua An

    Version of Record online : 10 OCT 2014, DOI: 10.1002/jps.24113

  3. Phase I Study of the Effect of Gastric Acid pH Modulators on the Bioavailability of Oral Dasatinib in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 49, Issue 6, June 2009, Pages: 700–709, Dr Timothy Eley, Dr Feng R. Luo, Dr Shruti Agrawal, Dr Ashish Sanil, Dr James Manning, Dr Tong Li, Dr Anne Blackwood-Chirchir and Dr Richard Bertz

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009333854

  4. You have free access to this content
    Chronic myeloid leukemia 2011: Successes, challenges, and strategies—Proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop

    American Journal of Hematology

    Volume 86, Issue 9, September 2011, Pages: 811–819, Tariq I. Mughal, Jerald P. Radich, Richard A. Van Etten, Alfonso Quintás-Cardama, Tomasz Skorski, Farhad Ravandi, Daniel J. DeAngelo, Carlo Gambacorti-Passerini, Giovanni Martinelli and Ayalew Tefferi

    Version of Record online : 17 AUG 2011, DOI: 10.1002/ajh.22097

  5. You have free access to this content
    Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management

    American Journal of Hematology

    Volume 87, Issue 11, November 2012, Pages: 1037–1045, Elias Jabbour and Hagop Kantarjian

    Version of Record online : 23 OCT 2012, DOI: 10.1002/ajh.23282

  6. You have free access to this content
    Practical management of patients with chronic myeloid leukemia


    Volume 117, Issue 19, 1 October 2011, Pages: 4343–4354, Francisco Cervantes and Michael Mauro

    Version of Record online : 16 MAR 2011, DOI: 10.1002/cncr.26062

  7. Targeting Fyn in Ras-transformed cells induces F-actin to promote adherens junction-mediated cell–cell adhesion

    Molecular Carcinogenesis

    Volume 54, Issue 10, October 2015, Pages: 1181–1193, Sarah E. Fenton, Kelli A. Hutchens and Mitchell F. Denning

    Version of Record online : 29 JUN 2014, DOI: 10.1002/mc.22190

  8. Clinical features of pulmonary arterial hypertension in patients receiving dasatinib

    American Journal of Hematology

    Volume 90, Issue 11, November 2015, Pages: 1060–1064, Neil P. Shah, Nicola Wallis, Harrison W. Farber, Michael J. Mauro, Robert A. Wolf, Daniele Mattei, Mausumee Guha, Delphine Rea and Andrew Peacock

    Version of Record online : 12 OCT 2015, DOI: 10.1002/ajh.24174

  9. Dasatinib inhibits mammary tumour development in a genetically engineered mouse model

    The Journal of Pathology

    Volume 230, Issue 4, August 2013, Pages: 430–440, Saadia A Karim, Helen Creedon, Hitesh Patel, Neil O Carragher, Jennifer P Morton, William J Muller, Thomas RJ Evans, Barry Gusterson, Owen J Sansom and Valerie G Brunton

    Version of Record online : 9 JUL 2013, DOI: 10.1002/path.4202

  10. You have free access to this content
    Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib

    International Journal of Cancer

    Volume 131, Issue 6, 15 September 2012, Pages: E916–E927, Nicole Hassold, Katharina Seystahl, Kristina Kempf, Doris Urlaub, Michael Zekl, Hermann Einsele, Carsten Watzl, Jörg Wischhusen and Ruth Seggewiss-Bernhardt

    Version of Record online : 4 APR 2012, DOI: 10.1002/ijc.27537

  11. High-performance liquid chromatography with solid-phase extraction for the quantitative determination of nilotinib in human plasma

    Biomedical Chromatography

    Volume 24, Issue 7, July 2010, Pages: 789–793, Masatomo Miura, Naoto Takahashi and Ken-ichi Sawada

    Version of Record online : 10 NOV 2009, DOI: 10.1002/bmc.1364

  12. Dasatinib inhibits progenitor cell proliferation from polycythaemia vera

    European Journal of Clinical Investigation

    Volume 38, Issue 8, August 2008, Pages: 578–584, M. Wappl, E. Jaeger, B. Streubel, H. Gisslinger, I. Schwarzinger, P. Valent and L. Oehler

    Version of Record online : 17 JUL 2008, DOI: 10.1111/j.1365-2362.2008.01982.x

  13. Novel agents to override imatinib resistance mechanisms

    Drug Development Research

    Volume 69, Issue 7, November 2008, Pages: 398–406, Asumi Yokota and Shinya Kimura

    Version of Record online : 23 DEC 2008, DOI: 10.1002/ddr.20271

  14. You have free access to this content
    Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia


    Volume 118, Issue 2, 15 January 2012, Pages: 300–311, Jerald P. Radich

    Version of Record online : 29 JUN 2011, DOI: 10.1002/cncr.26280

  15. You have free access to this content
    Dasatinib combined with docetaxel for castration-resistant prostate cancer


    Volume 118, Issue 1, 1 January 2012, Pages: 63–71, John C. Araujo, Paul Mathew, Andrew J. Armstrong, Edward L. Braud, Edwin Posadas, Mathew Lonberg, Gary E. Gallick, Géralyn C. Trudel, Prashni Paliwal, Shruti Agrawal and Christopher J. Logothetis

    Version of Record online : 4 MAR 2011, DOI: 10.1002/cncr.26204

  16. You have free access to this content
    Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D-first study

    American Journal of Hematology

    Volume 90, Issue 9, September 2015, Pages: 819–824, Noriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, Kimihiro Kawakami, Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto and Hisashi Sakamaki

    Version of Record online : 21 AUG 2015, DOI: 10.1002/ajh.24096

  17. You have free access to this content
    First-line therapy for chronic myeloid leukemia: Past, present, and future

    American Journal of Hematology

    Volume 84, Issue 5, May 2009, Pages: 287–293, Carolina Pavlovsky, Hagop Kantarjian and Jorge E. Cortes

    Version of Record online : 19 FEB 2009, DOI: 10.1002/ajh.21380

  18. You have free access to this content
    Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitro


    Volume 57, Issue 5, May 2013, Pages: 1838–1846, Richard S. Finn, Alexey Aleshin, Judy Dering, Peter Yang, Charles Ginther, Amrita Desai, Danyun Zhao, Erika von Euw, Ronald W. Busuttil and Dennis J. Slamon

    Version of Record online : 1 APR 2013, DOI: 10.1002/hep.26223

  19. You have full text access to this OnlineOpen article
    Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers

    FEBS Open Bio

    Volume 5, Issue 1, January 01, 2015, Pages: 542–549, Yusuke Oku, Naoyuki Nishiya, Toshiya Shito, Reiichiro Yamamoto, Yasufumi Yamamoto, Chihiro Oyama and Yoshimasa Uehara

    Version of Record online : 22 JUN 2015, DOI: 10.1016/j.fob.2015.06.007

  20. Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice

    British Journal of Dermatology

    Volume 168, Issue 1, January 2013, Pages: 112–119, S.H. Jung, X. Sun, W.-S. Ryu and B.-S. Yang

    Version of Record online : 21 DEC 2012, DOI: 10.1111/bjd.12069